11/18/2026 | Press release | Distributed by Public on 11/17/2026 21:50
Migraine care often focuses on what to do once an attack begins, but preventing a migraine before it starts is just as crucial as in-the-moment pain relief.
This year, we announced our Migraine Care Program, offering drug-free pain relief through Enso during a migraine, personalized trigger management, and expert-led prevention through exercise therapy. Today, we're adding another layer of prevention with a new waveform, FDA-cleared and designed to help make future attacks less likely, less severe, and less disruptive over time.
Daily prevention with Enso
Enso delivers gentle electrical pulses through gel pads placed on the forehead, targeting the trigeminal nerve, a key pain pathway involved in migraine. Now, the same device is designed to deliver treatment during a migraine and help reduce the frequency of future migraines with regular use over time.
Relief mode uses 101 Hz pulses to interrupt pain signals during an active attack. Prevention mode uses 60 Hz pulses for regular use between attacks, a frequency that is recommended for daily use in 20-minute sessions.
Working in tandem with the existing personalized trigger management, exercise therapy, and clinical support via the member's dedicated care team, this new capability empowers members to further tailor their migraine care to meet their individual needs between attacks. Together, these tools are designed to help members understand what may contribute to their migraines, respond when symptoms arise, and build habits that support less frequent attacks.
Designed to help reduce migraine days, and the costs that come with them.
Migraine is an exceptionally costly condition, both for the individual suffering from the symptoms and for the employer that is carrying the cost of their care. The Migraine Care Program is designed to address the three main drivers of migraine costs: pharmaceutical, medical and comorbid MSK spend.
Migraine costs U.S. businesses an estimated $78 billion each year.¹ At the individual level, Hinge Health analysis estimates preventative injections cost $9,000 to $12,600 per year, and oral acute and preventative medications can run up to $16,000 per year.²
Effective migraine care means fewer migraine days for members, and ultimately less reliance on medications and injections. Now, with the option for daily prevention through Enso and exercise therapy, the Migraine Care Program is built to do both.
Delivering better outcomes
Prevention mode adds even more value to an already-successful clinical model. To date, this program has been one of our fastest-adopted programs, with nearly 10,000 engaged members and a 9/10 average satisfaction score.
Members enter the program with roughly 6.5 migraine days per month on average. Surveyed members who engaged with the program experienced a 23% reduction in migraine days, or 1.3 migraine-free days back per month. When migraine headaches did occur, members reported they were shorter by roughly 5 hours, or a 28% reduction in the duration of the attack. These results also amounted to a 23% reduction in monthly prescription use days, which matters both for members and for the clients paying for their care.³